Interview with Mahaletchumy Arujanan, Executive Director, Malaysian…
How would you describe MABIC today and the way that it has evolved since its creation in 2000? The Malaysian Biotech Information Centre or MABIC is an NGO and part…
Address: Malaysian Biotechnology Information Centre (MABIC)
2-5-51, Monash University Malaysia
Jalan Lagoon Selatan, Bandar Sunway
46150 Petaling Jaya
Selangor D E
MALAYSIA
Tel: +603-5514 6178
The Malaysian Biotechnology Information Centre (MABIC) was set up in June 2000 to bridge the information gap amongst various stakeholder groups and to make technical information more accessible to non-technical individuals. MABIC is a not-for-profit, local node of a global network, with sister offices across all continents. MABIC’s parent institute is International Service for the Acquisition of Agri-biotech Applications (ISAAA). The aime of the Information Centre is to generate and foster closer relations amongst various stakeholders in order to enhance the exchange of information and knowledge these groups. MABIC strives to provide a platform where important issues in biotechnology can be explored and discussed.
Seminars, workshops and public forum are organised in collaboration with interested parties to create public awareness and to inform stakeholders of the current issues in biotechnology. MABIC also facilitates dialogues between stakeholder groups encouraging broad perspective discussions on various biotech topics. Additionally, MABIC also releases a series of publication on a weekly, monthly and quarterly basis.
With a mission to provide scientifically accurate and fact-based resources to all the stakeholders, MABIC strives to support the Government’s efforts in developing biotechnology as a tool for national development.
How would you describe MABIC today and the way that it has evolved since its creation in 2000? The Malaysian Biotech Information Centre or MABIC is an NGO and part…
“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis Malaysia’s president and managing director. Novartis, with 22 ongoing trials, is one of…
“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis Malaysia’s president and managing director. Novartis, with 22 ongoing trials, is one of…
“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis Malaysia’s president and managing director. Novartis, with 22 ongoing trials, is one of…
Klinsel’s CEO discusses the company’s ambitions of growth in a very competitive CRO market and stresses that local experience is truly a distinguishing factor and this is why they are…
Novo Nordisk Malaysia’s general manager shares the ongoing fight to cure diabetes and talks about the necessity to raise awareness, with for instance their current MoU with the ministry of…
Malaysia Healthcare Travel Council’s CEO is proud of her country’s healthcare system and their efforts at attracting medical tourists from all over the world, with the support of the healthcare…
Mundipharma Malaysia’s country manager discusses his company’s aim to become a reference in Malaysia for pain management, on the back of the tremendous 48 percent growth of the business last year. …
Lundbeck’s country manager gives a thorough overview of CNS disorders in Malaysia and states: “It is important to remind everyone that mental health conditions or brain diseases are not to…
MMA’s president shares the reasons why Malaysia is ranked today third in terms of healthcare quality, with a very efficient public system, high quality doctors and strong government support. However,…
IMS in Malaysia is possibly the first company to have signed a Memorandum of Understanding with the government for data provision. IMS Health’s general manager introduces this landmark and also…
Aspen Malaysia’s country manager details the company’s success in the country with a specific business model based on acquiring and remarketing originators. Although Aspen is a renowned generic player, market dynamics…
MGCC’s Executive Director discusses the opportunities and challenges for German pharma and healthcare companies to invest in Malaysia, at a time where most have decided to invest and base their…
See our Cookie Privacy Policy Here
